Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04136821 · ClinicalTrials.gov registry record · NA
The Long-term Effects of Oceanix™ on Resistance Training Adaptations
A NA study of Oxidative Stress and Body Composition, sponsored by Applied Science & Performance Institute.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT04136821: Completed NA study of Oxidative Stress and Body Composition, sponsored by Applied Science & Performance Institute.
NCT04136821 is a NA study of Oxidative Stress and Body Composition that has completed, run by Applied Science & Performance Institute. The registered enrollment target is 25 participants, below the 85-participant average among 36 other Oxidative Stress trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04136821, a NA study of Oxidative Stress and Body Composition, has completed, sponsored by Applied Science & Performance Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the effects of Oceanix™, an antioxidant supplement, on muscle performance, immune and endocrine function, recovery and safety in participants undergoing resistance training. Measures of muscle performance will include isometric testing in the bench-press and mid-thigh pull and ground reaction forces in the counter movement- and squat-jump. Markers of immune function will include salivary immunoglobulin A (IgA) as well as serum total antioxidant capacity (TAC) and superoxide dismutase (SOD) while endocrine function will be measured by salivary cortisol and testosterone. Recovery will be measure by plasma creatine kinase (CK) and perceptual measures will be assessed using a validated perceived recovery status (PRS) scale. Safety metrics will be indicated by a comprehensive metabolic panel (CMP), complete blood count (CBC), and urinalysis (UA). Additionally, the modified Borg Rating of Perceived Exertion (RPE) will be administered following each training session to grade physical exertion and monitor progression of the training protocol.
Primary Outcome
Assessed by isometric mid-thigh pull and isometric bench-press
Conditions Studied
Interventions
- OTHER Resistance Training
- DIETARY_SUPPLEMENT Oceanix
Study Locations (1)
Florida
- Applied Science & Performance Institute - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-09-30 |
| Est. Completion | 2020-01-31 |
| Phase | NA |
What the finished NCT04136821 record still lists
NCT04136821 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 85-participant average among 36 other Oxidative Stress trials with a reported enrollment target (71% lower).
The record links to 5 conditions, with Oxidative Stress appearing as the primary indexed condition, and to 2 interventions - of which Resistance Training is the first listed.
NCT04136821 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04136821 about?
NCT04136821 is a clinical study titled "The Long-term Effects of Oceanix™ on Resistance Training Adaptations". This study will examine the effects of Oceanix™, an antioxidant supplement, on muscle performance, immune and endocrine function, recovery and safety in participants undergoing resistance training. Measures of muscle performance will include isometric testing in the bench-press and mid-thigh pull an...
What is the current status of trial NCT04136821?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-09-30. Estimated completion is 2020-01-31.
What conditions does trial NCT04136821 study?
This clinical trial studies the following conditions: Oxidative Stress, Body Composition, Resistance Training, Muscle Damage, Muscle Strength.
What interventions are being tested in trial NCT04136821?
The interventions under investigation include: Resistance Training (OTHER), Oceanix (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04136821?
This trial is sponsored by Applied Science & Performance Institute, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04136821 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oxidative Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04136821's enrollment target sits among peer trials
25 27th of 36 higher than 10 of 36 other Oxidative Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Oxidative Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Impact of Haskap Berries on Recovery From High Intensity Resistance Training
RECRUITING · NA
-
The Effects of Endotracheal Suctioning on Pain and Serum Markers
RECRUITING · NA
-
Targeting Oxidative Stress to Prevent Vascular and Skeletal Muscle Dysfunction During Disuse
RECRUITING · NA
-
Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure
RECRUITING · NA
-
Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI